Document Detail


The CSF levels of total-tau and phosphotau in patients with relapsing-remitting multiple sclerosis.
MedLine Citation:
PMID:  15997419     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Total-tau protein is considered the marker of axon damage whereas the abnormally phosphorylated tau forms are mainly associated with Alzheimer's disease. An increase in total-tau levels was observed in neurodegenerative diseases, including multiple sclerosis (MS). In order to find out whether the phosphorylated tau forms occur in MS patients and to evaluate their clinical significance, the levels of total-tau (t-tau) and tau phosphorylated at Thr 181 (p-tau) were determined in 60 MS patients (40 during relapse including 18 with the first relapse and 20 stable) and in 18 age-matched controls. The determinations were conducted in the cerebrospinal fluid (CSF) using the ELISA method. The levels of t-tau and p-tau were higher in MS patients than in controls; however, increased levels were not related to the clinical activity of the disease. In CSF of the patients with the first relapse the level of t-tau was significantly increased whilst the level of p-tau was not elevated.
Authors:
H Bartosik-Psujek; Z Stelmasiak
Related Documents :
18474739 - Increased osteopontin levels in the cerebrospinal fluid of patients with multiple scler...
6221079 - Lymphocyte subpopulations in patients with multiple sclerosis.
9419499 - An index for diagnostic accuracy in the multiple disease setting.
18725589 - Cognitive assessment and quantitative magnetic resonance metrics can help to identify b...
17439889 - Advanced lightweight cooling-garment technology: functional improvements in thermosensi...
16921179 - Grey matter damage predicts the evolution of primary progressive multiple sclerosis at ...
22118859 - Stroke subtype classification: a comparative study of asco and modified toast.
21798229 - Contraction delay of the rv outflow tract in patients with brugada syndrome is dependen...
11448409 - Incidence and mechanism of presyncope and/or syncope associated with paroxysmal junctio...
Publication Detail:
Type:  Journal Article     Date:  2005-07-06
Journal Detail:
Title:  Journal of neural transmission (Vienna, Austria : 1996)     Volume:  113     ISSN:  0300-9564     ISO Abbreviation:  J Neural Transm     Publication Date:  2006 Mar 
Date Detail:
Created Date:  2006-02-02     Completed Date:  2006-10-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9702341     Medline TA:  J Neural Transm     Country:  Austria    
Other Details:
Languages:  eng     Pagination:  339-45     Citation Subset:  IM    
Affiliation:
Department of Neurology, Medical University of Lublin, Lublin, Poland. bartosikpsujek@op.pl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Biological Markers / analysis,  cerebrospinal fluid
Brain / metabolism*,  pathology,  physiopathology
Cerebrospinal Fluid / metabolism*
Enzyme-Linked Immunosorbent Assay
Female
Humans
Male
Microtubules / metabolism,  pathology
Multiple Sclerosis, Relapsing-Remitting / cerebrospinal fluid*,  diagnosis*,  physiopathology
Phosphorylation
Predictive Value of Tests
Up-Regulation / physiology
Wallerian Degeneration / cerebrospinal fluid,  diagnosis,  physiopathology
tau Proteins / cerebrospinal fluid*
Chemical
Reg. No./Substance:
0/Biological Markers; 0/tau Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Analysis of the polymorphic prion protein gene codon 129 in idiopathic Parkinson's disease.
Next Document:  Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective o...